Putnam Investments’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-44,848
| Closed | -$183K | – | 1228 |
|
|
2023
Q1 | $183K | Buy |
44,848
+14,710
| +49% | +$60K | ﹤0.01% | 1124 |
|
|
2022
Q4 | $151K | Sell |
30,138
-6,762
| -18% | -$33.9K | ﹤0.01% | 1128 |
|
|
2022
Q3 | $483K | Sell |
36,900
-666
| -2% | -$8.72K | ﹤0.01% | 941 |
|
|
2022
Q2 | $482K | Sell |
37,566
-446
| -1% | -$5.72K | ﹤0.01% | 948 |
|
|
2022
Q1 | $580K | Buy |
38,012
+9,920
| +35% | +$151K | ﹤0.01% | 966 |
|
|
2021
Q4 | $497K | Buy |
+28,092
| New | +$497K | ﹤0.01% | 1024 |
|